150 related articles for article (PubMed ID: 35262598)
1. Implications of Cannabis and Cannabinoid Use in COVID-19: Scoping Review.
Pereira CF; Vargas D; Toneloto FL; Ito VD; Volpato RJ
Rev Bras Enferm; 2022; 75Suppl 1(Suppl 1):e20201374. PubMed ID: 35262598
[TBL] [Abstract][Full Text] [Related]
2. Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection.
Janecki M; Graczyk M; Lewandowska AA; Pawlak Ł
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456990
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and
Mahmud MS; Hossain MS; Ahmed ATMF; Islam MZ; Sarker ME; Islam MR
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885798
[TBL] [Abstract][Full Text] [Related]
4. Cannabis as antivirals.
Sea YL; Gee YJ; Lal SK; Choo WS
J Appl Microbiol; 2023 Jan; 134(1):. PubMed ID: 36626776
[TBL] [Abstract][Full Text] [Related]
5. The Role of
Altyar AE; Youssef FS; Kurdi MM; Bifari RJ; Ashour ML
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566148
[No Abstract] [Full Text] [Related]
6. Potential Neuroprotective Effect of Cannabinoids in COVID-19 Patients.
Cortes-Altamirano JL; Yáñez-Pizaña A; Reyes-Long S; Angélica GM; Bandala C; Bonilla-Jaime H; Alfaro-Rodríguez A
Curr Top Med Chem; 2022; 22(16):1326-1345. PubMed ID: 35382723
[TBL] [Abstract][Full Text] [Related]
7. Co-exposure of cocaine and cannabinoids and its association with select biological, behavioural and health outcomes: A systematic scoping review of multi-disciplinary studies.
Daldegan-Bueno D; Maia LO; Glass M; Jutras-Aswad D; Fischer B
Eur Neuropsychopharmacol; 2021 Oct; 51():106-131. PubMed ID: 34273801
[TBL] [Abstract][Full Text] [Related]
8. Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies.
Daldegan-Bueno D; Maia LO; Glass M; Jutras-Aswad D; Fischer B
Psychopharmacology (Berl); 2022 May; 239(5):1211-1230. PubMed ID: 34613429
[TBL] [Abstract][Full Text] [Related]
9. Cannabis and cannabinoids: pharmacology and therapeutic potential.
Śmiarowska M; Białecka M; Machoy-Mokrzyńska A
Neurol Neurochir Pol; 2022; 56(1):4-13. PubMed ID: 35133644
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?
Croxford JL; Yamamura T
J Neuroimmunol; 2005 Sep; 166(1-2):3-18. PubMed ID: 16023222
[TBL] [Abstract][Full Text] [Related]
11. Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping review.
Bonnet U; Specka M; Roser P; Scherbaum N
J Neural Transm (Vienna); 2023 Jan; 130(1):7-18. PubMed ID: 36346483
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of cannabinoids.
Grotenhermen F
Clin Pharmacokinet; 2003; 42(4):327-60. PubMed ID: 12648025
[TBL] [Abstract][Full Text] [Related]
13. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Pertwee RG
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
[TBL] [Abstract][Full Text] [Related]
14. In search of preventive strategies: novel high-CBD
Wang B; Kovalchuk A; Li D; Rodriguez-Juarez R; Ilnytskyy Y; Kovalchuk I; Kovalchuk O
Aging (Albany NY); 2020 Nov; 12(22):22425-22444. PubMed ID: 33221759
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids in clinical practice.
Williamson EM; Evans FJ
Drugs; 2000 Dec; 60(6):1303-14. PubMed ID: 11152013
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids - a new weapon against cancer?
Pokrywka M; Góralska J; Solnica B
Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1309-1320. PubMed ID: 28100841
[TBL] [Abstract][Full Text] [Related]
17. Role of Cannabinoids in Various Diseases: A Review.
Kaur S; Sharma N; Roy A
Curr Pharm Biotechnol; 2022; 23(11):1346-1358. PubMed ID: 34951355
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid Use in a Tertiary Headache Clinic: A Cross-Sectional Survey.
Melinyshyn AN; Amoozegar F
Can J Neurol Sci; 2022 Nov; 49(6):781-790. PubMed ID: 34511153
[TBL] [Abstract][Full Text] [Related]
19. Cannabis/Cannabinoids for Treating COVID-19 Associated Neuropsychiatric Complications.
Khalsa JH; Maggirwar SB; Bunt G
J Neuroimmune Pharmacol; 2021 Dec; 16(4):718-721. PubMed ID: 34655372
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoids: for better and for worse
.
Thibaut F; Hoehe MR
Dialogues Clin Neurosci; 2020 Sep; 22(3):201-204. PubMed ID: 33162763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
